Jane Street’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-18,500
| Closed | -$14.2K | – | 11959 |
|
|
2026
Q1 | $14.2K | Sell |
18,500
-19,442
| -51% | -$18.4K | ﹤0.01% | 11257 |
|
|
2025
Q4 | $41.7K | Sell |
37,942
-1,481
| -4% | -$1.73K | ﹤0.01% | 10557 |
|
|
2025
Q3 | $45K | Buy |
39,423
+24,400
| +162% | +$30.9K | ﹤0.01% | 10378 |
|
|
2025
Q2 | $19.2K | Sell |
15,023
-18,709
| -55% | -$22.9K | ﹤0.01% | 9365 |
|
|
2025
Q1 | $42.2K | Buy |
33,732
+12,387
| +58% | +$18.7K | ﹤0.01% | 9041 |
|
|
2024
Q4 | $39.9K | Buy |
+21,345
| New | +$42.1K | ﹤0.01% | 9025 |
|
|
2023
Q3 | – | Sell |
-2,747
| Closed | -$29.4K | – | 8824 |
|
|
2023
Q2 | $29.4K | Buy |
+2,747
| New | +$18.6K | ﹤0.01% | 8312 |
|
|
2022
Q2 | – | Sell |
-6,525
| Closed | -$85K | – | 9945 |
|
|
2022
Q1 | $85K | Sell |
6,525
-1,891
| -22% | -$25.5K | ﹤0.01% | 9521 |
|
|
2021
Q4 | $138K | Buy |
8,416
+5,068
| +151% | +$115K | ﹤0.01% | 9051 |
|
|
2021
Q3 | $88K | Sell |
3,348
-4,166
| -55% | -$122K | ﹤0.01% | 9355 |
|
|
2021
Q2 | $257K | Buy |
7,514
+4,027
| +115% | +$158K | ﹤0.01% | 8418 |
|
|
2021
Q1 | $176K | Sell |
3,487
-14,076
| -80% | -$871K | ﹤0.01% | 8353 |
|
|
2020
Q4 | $825K | Buy |
17,563
+7,329
| +72% | +$258K | ﹤0.01% | 4983 |
|
|
2020
Q3 | $405K | Buy |
10,234
+8,073
| +374% | +$144K | ﹤0.01% | 5469 |
|
|
2020
Q2 | $22K | Sell |
2,161
-1,039
| -32% | -$11.3K | ﹤0.01% | 6959 |
|
|
2020
Q1 | $38K | Buy |
3,200
+1,938
| +154% | +$26.7K | ﹤0.01% | 5120 |
|
|
2019
Q4 | $19K | Sell |
1,262
-2,312
| -65% | -$34.5K | ﹤0.01% | 4953 |
|
|
2019
Q3 | $56K | Buy |
3,574
+690
| +24% | +$10.9K | ﹤0.01% | 4865 |
|
|
2019
Q2 | $46K | Sell |
2,884
-774
| -21% | -$14.3K | ﹤0.01% | 4965 |
|
|
2019
Q1 | $67K | Buy |
3,658
+81
| +2% | +$1.71K | ﹤0.01% | 4800 |
|
|
2018
Q4 | $71K | Buy |
+3,577
| New | +$90.4K | ﹤0.01% | 4682 |
|
|
2018
Q1 | – | Sell |
-8,517
| Closed | -$262K | – | 4934 |
|
|
2017
Q4 | $262K | Buy |
8,517
+6,793
| +394% | +$267K | ﹤0.01% | 3907 |
|
|
2017
Q3 | $77K | Buy |
+1,724
| New | +$82.1K | ﹤0.01% | 4299 |
|
|
2017
Q2 | – | Sell |
-5,013
| Closed | -$268K | – | 4466 |
|
|
2017
Q1 | $268K | Buy |
5,013
+2,084
| +71% | +$109K | ﹤0.01% | 3569 |
|
|
2016
Q4 | $149K | Buy |
+2,929
| New | +$168K | ﹤0.01% | 3807 |
|
|
2016
Q3 | – | Sell |
-1,253
| Closed | -$78K | – | 4123 |
|
|
2016
Q2 | $78K | Buy |
1,253
+208
| +20% | +$14.5K | ﹤0.01% | 3918 |
|
|
2016
Q1 | $68K | Buy |
+1,045
| New | +$71.7K | ﹤0.01% | 3935 |
|
|
2014
Q2 | – | Sell |
-2,874
| Closed | -$547K | – | 2708 |
|
|
2014
Q1 | $547K | Buy |
+2,874
| New | +$545K | 0.01% | 1489 |
|
Other funds holding EVGN
HF
XT
DSC
FDCDDQ
Jane Street's EVGN Position: Q2 2026 in Review
Jane Street sold out of Evogene (EVGN) in Q2 2026, closing a stake of 18,500 shares — an estimated $14.2K sold.
Jane Street first reported a position in EVGN in Q1 2014 and held it in 28 quarters. The position peaked at $825K in Q4 2020. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.
- Jane Street reported no remaining Evogene position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 18,500 Evogene shares in Q2 2026, an estimated $14.2K.
- Jane Street first reported a position in Evogene in Q1 2014 and held it in 28 quarters.
- Jane Street's Evogene position peaked at $825K in Q4 2020.
- 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.